The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis (Q24604736)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis	scientific article

Statements

scholarly article

0 references

7 references

14 March 2019

19 March 2019

24 March 2019

22 April 2019

17 June 2019

17 September 2019

2 October 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis (English)

0 references

0 references

cardiovascular disease

7 references

14 March 2019

19 March 2019

24 March 2019

22 April 2019

17 June 2019

17 September 2019

2 October 2020

hyperhomocysteinemia

8 references

14 March 2019

19 March 2019

24 March 2019

22 April 2019

17 June 2019

17 September 2019

29 May 2020

2 October 2020

7 references

14 March 2019

19 March 2019

24 March 2019

22 April 2019

17 June 2019

17 September 2019

2 October 2020

heterocyclic compound

1 reference

17 September 2019

1 reference

2 October 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

object named as

Vlado Perkovic

author given names

Vlado

author last names

Perkovic

1 reference

20 October 2023

3

object named as

Sophia Zoungas

author given names

Sophia

author last names

Zoungas

1 reference

20 October 2023

object named as

Meg J Jardine

1

author given names

Meg J

author last names

Jardine

1 reference

20 October 2023

Giovanni Strippoli

object named as

Giovanni Strippoli

9

author given names

Giovanni

author last names

Strippoli

1 reference

20 October 2023

object named as

Alan Cass

8

author given names

Alan

author last names

Cass

1 reference

20 October 2023

Sankar Navaneethan

4

object named as

Sankar D Navaneethan

author given names

Sankar D

author last names

Navaneethan

1 reference

20 October 2023

Toshiharu Ninomiya

5

object named as

Toshiharu Ninomiya

author given names

Toshiharu

author last names

Ninomiya

1 reference

20 October 2023

Sagar U Nigwekar

6

object named as

Sagar U Nigwekar

author given names

Sagar U

author last names

Nigwekar

1 reference

20 October 2023

2

object named as

Amy Kang

author given names

Amy

author last names

Kang

1 reference

20 October 2023

author name string

Martin P Gallagher

7

author given names

Martin P

author last names

Gallagher

1 reference

20 October 2023

language of work or name

0 references

publication date

13 June 2012

8 references

14 March 2019

19 March 2019

24 March 2019

22 April 2019

17 June 2019

17 September 2019

29 May 2020

2 October 2020

8 references

14 March 2019

19 March 2019

24 March 2019

22 April 2019

17 June 2019

17 September 2019

29 May 2020

2 October 2020

344

0 references

e3533

0 references

jun13 2

0 references

copyright license

Creative Commons Attribution-NonCommercial

7 references

14 March 2019

19 March 2019

24 March 2019

22 April 2019

17 June 2019

17 September 2019

2 October 2020

on focus list of Wikimedia project

0 references

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

7 April 2017

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

7 April 2017

Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

7 April 2017

Homocysteine lowering and cardiovascular events after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

7 April 2017

Homocysteine lowering with folic acid and B vitamins in vascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

7 April 2017

Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

7 April 2017

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

7 April 2017

Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

5-methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Efficacy of folic acid supplementation in stroke prevention: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Classical homocystinuria: vascular risk and its prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

27 September 2017

Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

30 May 2018

Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

30 May 2018

What is the meaning of homocysteine in patients on dialysis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

Homocysteine or renal impairment: which is the real cardiovascular risk factor?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

The influence of estimated creatinine clearance on plasma homocysteine in hypertensive patients with normal serum creatinine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

Relationship between homocysteine and mortality in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

Homocysteine and its determinants in nondialyzed chronic kidney disease patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

Elevated homocysteine levels in patients with end-stage renal disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374481

28 November 2018

Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22695899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular disease in chronic renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22695899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22695899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population reference values for plasma total homocysteine concentrations in US adults after the fortification of cereals with folic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/22695899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated homocysteine is a predictor of all-cause mortality in a prospective cohort of renal transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22695899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events

1 reference

https://pubmed.ncbi.nlm.nih.gov/22695899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.E3533

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24604736&oldid=1994100619"